Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Pablo G Legorreta
AddedFeb 20, 2024
UpdatedJun 28, 2026
Pablo G Legorreta

Pablo G Legorreta

Founder, Pharmakon Advisors

CrunchbaseLinkedInThe Org

Pablo G Legorreta's Career

Pharmakon Advisors
Pharmakon Advisors

New York City, NY, US

Founder
Royalty Pharma
Royalty Pharma

New York City, NY, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Pablo G Legorreta's Career

Pharmakon Advisors
Pharmakon Advisors
Investment FirmInvestment Firm102009New York City, NY, US
Founder

Leadership at Pharmakon Advisors

Pedro Gonzalez de CosioPedro Gonzalez de CosioCEO

Similar to Pharmakon Advisors

Apothecary CapitalApothecary CapitalChicago, IL, USest. 2003Apothecary CapitalChicago, IL, US · est. 2003

Apothecary Capital LLC: A US-based financial advisory and venture capital firm.

Investment Firm5
PharmaBio InvestmentsPharmaBio InvestmentsDurham, NC, USPharmaBio InvestmentsDurham, NC, US

Durham-based financial services firm specializing in investments.

Investment Firm6
Partners for GrowthPartners for GrowthSan Francisco, CA, USest. 2004Partners for GrowthSan Francisco, CA, US · est. 2004

Partners for Growth LP: A loan structuring advisor offering custom debt solutions to tech and life science firms.

Investment Firm30
Bain Capital Life SciencesBain Capital Life SciencesBoston, MA, USest. 2016Bain Capital Life SciencesBoston, MA, US · est. 2016

Bain Capital Life Sciences Fund LP: Boston-based buyout specialist in life sciences.

Investment Firm30
Royalty Pharma
Royalty Pharma
Public751996New York City, NY, US
Board Member· Board

Leadership at Royalty Pharma

Rory RiggsRory RiggsBoard Member
Cathy EngelbertCathy EngelbertBoard Member
Henry FernandezHenry FernandezBoard Member
David HodgsonDavid HodgsonBoard Member
Ted LoveTed LoveBoard Member
Christopher HiteChristopher HiteBoard Member

Similar to Royalty Pharma

Roivant SciencesRoivant SciencesNew York City, NY, USDrug Developmentest. 2014Roivant SciencesNew York City, NY, US · est. 2014

NY-based Roivant Sciences is a biopharmaceutical firm dedicated to advancing promising drugs for patient care.

Public · $2.5B267
XOMA RoyaltyXOMA RoyaltyEmeryville, CA, USRoyalty Acquisitionest. 1981XOMA RoyaltyEmeryville, CA, US · est. 1981

XOMA Corporation, a biotech royalty aggregator, acquires economic rights to clinical candidates, aiding health improvement.

Public · $295.8M96
AstraZenecaAstraZenecaCambridge, Cambridgeshire, GBPharmaceuticalsest. 1999AstraZenecaCambridge, Cambridgeshire, GB · est. 1999

AstraZeneca PLC: A British-Swedish firm specializing in research, manufacturing, and sales of pharmaceuticals.

Public · $3.8B83.5k
PharmosPharmosIselin, NJ, USDrug Developmentest. 1982PharmosIselin, NJ, US · est. 1982

W World Corp.: A bio-pharmaceutical firm innovating new drugs for neuroinflammatory disorders.

Public · $9.5M2

Pablo G Legorreta's Co-Investors

Almudena LegorretaAlmudena LegorretaCo-invested · Brown University Grant

Pablo G Legorreta's Similar Executives & Operators

Soemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakWillix HalimWillix HalimCEO · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakHaeil YiHaeil YiCo-Founder · DunamuLee Sirg-OoLee Sirg-OoCEO · Dunamu

People Similar to Pablo G Legorreta

Paul LeePaul LeeCo-Founder · Builders VCGeorge Roby ThomasGeorge Roby ThomasCEO · R K PharmaMark RandallMark RandallFounder & CEO · Renaissance Capital PartnersRonald GoldRonald GoldBoard Member · NJ BioJonathan KoganJonathan KoganFounder · RPA ToolsRicardo MajelaRicardo MajelaCo-Founder · Worthix